Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications.

Chigutsa E, Visser ME, Swart EC, Denti P, Pushpakom S, Egan D, Holford NH, Smith PJ, Maartens G, Owen A, McIlleron H.

Antimicrob Agents Chemother. 2011 Sep;55(9):4122-7. doi: 10.1128/AAC.01833-10. Epub 2011 Jun 27.

PMID:
21709081
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations.

Weiner M, Peloquin C, Burman W, Luo CC, Engle M, Prihoda TJ, Mac Kenzie WR, Bliven-Sizemore E, Johnson JL, Vernon A.

Antimicrob Agents Chemother. 2010 Oct;54(10):4192-200. doi: 10.1128/AAC.00353-10. Epub 2010 Jul 26.

PMID:
20660695
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.

Zhou Q, Chen QX, Ruan ZR, Yuan H, Xu HM, Zeng S.

Pharmazie. 2013 Mar;68(3):187-94.

PMID:
23556337
[PubMed - indexed for MEDLINE]
4.

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.

Niemi M, Backman JT, Kajosaari LI, Leathart JB, Neuvonen M, Daly AK, Eichelbaum M, Kivistö KT, Neuvonen PJ.

Clin Pharmacol Ther. 2005 Jun;77(6):468-78.

PMID:
15961978
[PubMed - indexed for MEDLINE]
5.

Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism.

He YJ, Zhang W, Chen Y, Guo D, Tu JH, Xu LY, Tan ZR, Chen BL, Li Z, Zhou G, Yu BN, Kirchheiner J, Zhou HH.

Clin Chim Acta. 2009 Jul;405(1-2):49-52. doi: 10.1016/j.cca.2009.04.003. Epub 2009 Apr 14.

PMID:
19374892
[PubMed - indexed for MEDLINE]
6.

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.

Niemi M, Pasanen MK, Neuvonen PJ.

Clin Pharmacol Ther. 2006 Oct;80(4):356-66.

PMID:
17015053
[PubMed - indexed for MEDLINE]
7.

Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance.

Schipani A, Siccardi M, D'Avolio A, Baietto L, Simiele M, Bonora S, Rodríguez Novoa S, Cuenca L, Soriano V, Chierakul N, Saguenwong N, Chuchuttaworn C, Hoskins JM, Dvorak AM, McLeod HL, Davies G, Khoo S, Back DJ, Di Perri G, Owen A.

Antimicrob Agents Chemother. 2010 Dec;54(12):5242-50. doi: 10.1128/AAC.00781-10. Epub 2010 Oct 4.

PMID:
20921307
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.

Ruslami R, Nijland HM, Alisjahbana B, Parwati I, van Crevel R, Aarnoutse RE.

Antimicrob Agents Chemother. 2007 Jul;51(7):2546-51. Epub 2007 Apr 23.

PMID:
17452486
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.

Hedman M, Antikainen M, Holmberg C, Neuvonen M, Eichelbaum M, Kivistö KT, Neuvonen PJ, Niemi M.

Br J Clin Pharmacol. 2006 Jun;61(6):706-15.

PMID:
16722833
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.

Zhou Q, Ruan ZR, Yuan H, Xu DH, Zeng S.

Pharmazie. 2013 Feb;68(2):129-34.

PMID:
23469685
[PubMed - indexed for MEDLINE]
11.

Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms.

Zhou Q, Ruan ZR, Jiang B, Yuan H, Zeng S.

Pharmazie. 2013 Feb;68(2):124-8.

PMID:
23469684
[PubMed - indexed for MEDLINE]
12.

Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin.

Niemi M, Kivistö KT, Diczfalusy U, Bodin K, Bertilsson L, Fromm MF, Eichelbaum M.

Pharmacogenet Genomics. 2006 Aug;16(8):565-8.

PMID:
16847425
[PubMed - indexed for MEDLINE]
13.

SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury.

Li LM, Chen L, Deng GH, Tan WT, Dan YJ, Wang RQ, Chen WS.

Mol Med Rep. 2012 Jul;6(1):75-82. doi: 10.3892/mmr.2012.900. Epub 2012 May 3.

PMID:
22562052
[PubMed - indexed for MEDLINE]
14.

Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.

Bernsdorf A, Giessmann T, Modess C, Wegner D, Igelbrink S, Hecker U, Haenisch S, Cascorbi I, Terhaag B, Siegmund W.

Br J Clin Pharmacol. 2006 Apr;61(4):440-50.

PMID:
16542205
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Genetic variation in ABCB1 influences paclitaxel pharmacokinetics in Japanese patients with ovarian cancer.

Yamaguchi H, Hishinuma T, Endo N, Tsukamoto H, Kishikawa Y, Sato M, Murai Y, Hiratsuka M, Ito K, Okamura C, Yaegashi N, Suzuki N, Tomioka Y, Goto J.

Int J Gynecol Cancer. 2006 May-Jun;16(3):979-85.

PMID:
16803472
[PubMed - indexed for MEDLINE]
16.

The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men.

Kohlrausch FB, de Cássia Estrela R, Barroso PF, Suarez-Kurtz G.

Br J Clin Pharmacol. 2010 Jan;69(1):95-8. doi: 10.1111/j.1365-2125.2009.03551.x.

PMID:
20078617
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.

Tian L, Liu H, Xie S, Jiang J, Han L, Huang Y, Li Y.

Clin Ther. 2011 May;33(5):655-63. doi: 10.1016/j.clinthera.2011.04.018.

PMID:
21665049
[PubMed - indexed for MEDLINE]
18.

Effects of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of atorvastatin and 2-hydroxyatorvastatin in healthy Korean subjects.

Lee YJ, Lee MG, Lim LA, Jang SB, Chung JY.

Int J Clin Pharmacol Ther. 2010 Jan;48(1):36-45.

PMID:
20040338
[PubMed - indexed for MEDLINE]
19.

Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers.

Aquilante CL, Bushman LR, Knutsen SD, Burt LE, Rome LC, Kosmiski LA.

Hum Genomics. 2008 Sep;3(1):7-16.

PMID:
19129086
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.

Zhang W, He YJ, Gan Z, Fan L, Li Q, Wang A, Liu ZQ, Deng S, Huang YF, Xu LY, Zhou HH.

Clin Exp Pharmacol Physiol. 2007 Dec;34(12):1240-4.

PMID:
17973861
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk